China's GCP, first issued in 2003 and revised in 2020, is quality standards for the whole process of drug clinical trials. 

Contents:

   Chapter I: General Provisions

   Chapter II: Glossary and Definition

   Chapter III: Ethnics Committee

   Chapter IV: Investigator

   Chapter V: Applicant

   Chapter VI: Trial Protocol

   Chapter VII: Investigator's Brochure

   Chapter VIII: Management of Essential Documents

   Chapter IX: Supplementary Provisions